NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
This Quarter Return
+4.22%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.18B
AUM Growth
+$1.18B
Cap. Flow
-$98.1M
Cap. Flow %
-8.35%
Top 10 Hldgs %
96.84%
Holding
15
New
–
Increased
1
Reduced
2
Closed
1

Top Buys

1
ELDN icon
Eledon Pharmaceuticals
ELDN
$58.8K

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$46.1M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
$45.6M
3
XENT
Intersect ENT, Inc
XENT
$6.49M

Sector Composition

1 Healthcare 59.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$526B
$320M 27.18% 2,979,100 – –
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$228M 19.43% 4,910,487 -991,332 -17% -$46.1M
VGK icon
3
Vanguard FTSE Europe ETF
VGK
$26.8B
$114M 9.69% 2,101,000 – –
INGN icon
4
Inogen
INGN
$216M
$114M 9.66% 3,549,320 – –
NVRO
5
DELISTED
NEVRO CORP.
NVRO
$105M 8.95% 2,194,841 – –
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$92.4M 7.86% 3,201,183 – –
OTIC
7
DELISTED
Otonomy, Inc.
OTIC
$76.9M 6.54% 2,175,025 – –
FLXN
8
DELISTED
Flexion Therapeutics, Inc.
FLXN
$51.4M 4.37% 2,283,131 – –
AKBA icon
9
Akebia Therapeutics
AKBA
$833M
$16.8M 1.43% 1,516,387 – –
ELDN icon
10
Eledon Pharmaceuticals
ELDN
$155M
$13.4M 1.14% 1,184,196 +5,204 +0.4% +$58.8K
AERI
11
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$13.2M 1.12% 419,652 – –
TTPH
12
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$8.48M 0.72% 231,419 -1,243,581 -84% -$45.6M
XENE icon
13
Xenon Pharmaceuticals
XENE
$2.98B
$2.15M 0.18% 127,563 – –
XENT
14
DELISTED
Intersect ENT, Inc
XENT
– – -350,000 Closed -$6.49M